Skip to main content
. 2016 Jul 6;7(43):70969–70978. doi: 10.18632/oncotarget.10450

Figure 1. CONSORT diagram of the study design.

Figure 1

Arm A treatment consisted of paclitaxel plus cisplatin chemotherapy combined with radiotherapy. Arm B treatment consisted of paclitaxel plus cisplatin chemoradiotherapy followed by paclitaxel plus cisplatin consolidation chemotherapy. LTFU: lost to follow-up.